From PCOS to PMOS: The Impact of Physical Activity, Diet, and Metabolic Health on the Course of Polyendocrine Metabolic Ovarian Syndrome
DOI:
https://doi.org/10.12775/QS.2026.70.74736Keywords
PMOS, Polyendocrine Metabolic Ovarian Syndrome PMOS; physical activity; exercise; diet; metabolic health; lifestyle intervention.Abstract
Introduction: Polyendocrine Metabolic Ovarian Syndrome (PMOS), previously called polycystic ovary syndrome (PCOS), is now recognized as a complex endocrine–metabolic disorder rather than a solely ovarian condition. Lifestyle modification is central to management, with growing focus on physical activity, nutrition, and long-term metabolic health.
Aim: To summarize current evidence on the effects of physical activity, dietary interventions, and metabolic health on PMOS, and to highlight the importance of individualized lifestyle management.
Material and methods: A narrative review was conducted using PubMed and Google Scholar publications from 2018 to 2026. The review included international guidelines, systematic reviews, meta-analyses, randomized controlled trials, and high-quality observational studies on lifestyle interventions in women with PMOS/PCOS.
Results: Evidence shows that regular physical activity and individualized dietary interventions improve insulin sensitivity, body composition, lipid profile, and cardiometabolic health. Aerobic exercise has the strongest support for metabolic improvement, while resistance training and high-intensity interval training (HIIT) may offer additional benefits for some patients. Mediterranean, low-glycaemic index, and anti-inflammatory diets are linked to better metabolic and hormonal control. Notably, metabolic improvements can occur without significant weight loss, highlighting the importance of lifestyle quality over body weight alone.
Conclusions: Lifestyle modification is the foundation of PMOS management. Individualized physical activity, high-quality dietary counseling, and regular metabolic monitoring should be integrated into multidisciplinary, patient-centered care to improve clinical outcomes and quality of life for women with PMOS.
References
1. World Health Organization. Polycystic ovary syndrome. Geneva: World Health Organization; 2026 [cited 2026 Jul 2]. https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome
2. Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Hum Reprod. 2023;38(9):1655-1679. DOI: 10.1093/humrep/dead156
3. Monash University. International Evidence-Based Guideline for Polycystic Ovary Syndrome 2023. Melbourne: Monash University; 2023 [cited 2026 Jul 2]. Available from: https://www.monash.edu/medicine/mchri/pcos/guideline
4. Forslund M, Melin J, Stener-Victorin E, et al. International evidence-based guideline on assessment and management of polycystic ovary syndrome: a Nordic perspective. Acta Obstet Gynecol Scand. 2024;103(1):5-15.DOI: 10.1111/aogs.14725
5. Tay CT, Joham AE, Boyle JA, et al. 2023 International Evidence-Based Polycystic Ovary Syndrome Guideline and cardiovascular disease risk. Clin Endocrinol (Oxf). 2024. DOI: 10.1161/JAHA.123.033572
6. Cowan S, Lim S, Alycia C, et al. Lifestyle management in polycystic ovary syndrome: beyond diet and physical activity. BMC Endocr Disord. 2023;23:14. DOI: 10.1186/s12902-022-01208-y
7. Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations From the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-2469. doi:10.1210/clinem/dgad463.
8. Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Eur J Endocrinol. 2023;189(2). doi:10.1093/ejendo/lvad096. PMID: 37580861.
9. Moslehi, N., Zeraattalab-Motlagh, S., Rahimi Sakak, F., Shab-Bidar, S., Tehrani, F. R., & Mirmiran, P. (2023). Effects of nutrition on metabolic and endocrine outcomes in women with polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials. Nutrition reviews, 81(5), 555–577. https://doi.org/10.1093/nutrit/nuac075
10. Akbaş, E., Samancı, M., & Öztürk, Y. E. (2026). Nutrition interventions in women with polycystic ovary syndrome: a systematic review. European journal of nutrition, 65(5), 176. https://doi.org/10.1007/s00394-026-04030-7
11. Scannell, N., Villani, A., Moran, L., & Mantzioris, E. (2025). The potential role of the Mediterranean diet for the treatment and management of polycystic ovary syndrome: a review of the pathophysiological mechanisms and clinical evidence. The Proceedings of the Nutrition Society, 84(2), 176–187. https://doi.org/10.1017/S0029665124007584
12. Aboeldalyl, S., James, C., Seyam, E., Ibrahim, E. M., Shawki, H. E., & Amer, S. (2021). The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis. International journal of molecular sciences, 22(5), 2734. https://doi.org/10.3390/ijms22052734
13. Patten RK, Boyle RA, Moholdt T, Kiel I, Hopkins WG, Harrison CL, et al. Exercise interventions in polycystic ovary syndrome: a systematic review and meta-analysis. Front Physiol. 2020;11:606. https://doi.org/10.3389/fphys.2020.00606
14. Santos IKD, Nunes FASdS, Queiros VS, Cobucci RN, Dantas PB, Soares GM, et al. Effect of high-intensity interval training on metabolic parameters in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2021;16(1):e0245023. https://doi.org/10.1371/journal.pone.0245023
15. Atmaca L, Chauhan S, Najaf SS, Elmadani M, Al-Jawarneh M, Soloh A, et al. Effectiveness of exercise interventions on androgen and sex hormone-binding globulin levels in women with polycystic ovary syndrome: a systematic review and meta-analysis. Front Sports Act Living. 2026;7:1686566. https://doi.org/10.3389/fspor.2025.1686566
16. Molinaro M, Greco F, Ingargiola A, Raffa A, Greco EA, Emerenziani GP, et al. Effects of physical exercise on menstrual symptoms in polycystic ovary syndrome: a systematic review. J Endocrinol Invest. 2026. https://doi.org/10.1007/s40618-026-02836-0
17. Motaharinezhad F, Emadi A, Hosnian M, Kheirkhahan A, Jayedi A, Ehsani F. The effects of different exercises on weight loss and hormonal changes in women with polycystic ovarian syndrome: a network meta-analysis study. BMC Womens Health. 2024;24:512. https://doi.org/10.1186/s12905-024-03297-4
18. Bartold, M., Pohrybieniuk, J., Piotraszewska, M., Grys, M., Kochański, F., Wołk, K., … Pietrzak, J. (2025). Physical Activity vs. Pharmacotherapy in PCOS Treatment: A relief of Clinical Evidence on Exercise and Metformine Efficacy. Quality in Sport, 44, 62921. https://doi.org/10.12775/QS.2025.44.62921
19. Biskup, A., Wnęk, A., Smagowska, J., Staszko, N., Kala-Kaziszyn, E., Bała, K., & Stańko, M. (2026). Inositols in PCOS/PMOS: therapeutic role, metabolic implications, and combination with metformin. Quality in Sport, 58, 72611. https://doi.org/10.12775/QS.2026.58.72611
20. Pirga, G., Chwajta, G., Kaczor, G., Cichocka, W., Cepielik, B., Antos, M., … Jędruszko, K. (2026). The Influence of Polyendocrine Metabolic Ovarian Syndrome on Training Adaptations and Athletic Performance . Quality in Sport, 62, 73200. https://doi.org/10.12775/QS.2026.62.73200
21. Turek, M., Wojciechowska, K., Jaroń, A., Jastrzębska, K., Wiklińska, A., Witkowska, M., Sawicki, M. (2024). PCOS – The Importance of Diet, Physical Activity, and Other Non-Pharmacological Methods in Treatment. Quality in Sport, 19, 53833. https://doi.org/10.12775/QS.2024.19.53833
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Zuzanna Michalik, Zuzanna Kryś, Karol Mirkowski , Michał Chodor

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 171
Number of citations: 0